Precision Medicine Market Growth, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Precision Medicine Market covers analysis By Technology (Drug Discovery, Companion Diagnostics, Gene Sequencing, Bio-Informatics, Big Data Analytics); Application (Oncology, Respiratory, CNS, Infectious Diseases, Immunology, Cardiology, Other Applications) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Jan 2026
  • Report Code : TIPBT00002184
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Jan 2025

The Precision Medicine Market size is expected to reach US$ 271.17 billion by 2031. The market is anticipated to register a CAGR of 12.8% during 2025-2031.

The Precision Medicine Market is categorized by technology into the following subsegments: Drug Discovery, Companion Diagnostics, Gene Sequencing, Bio-Informatics, Big Data Analytics. It further presents an analysis based on application, i.e., Oncology, Respiratory, CNS, Infectious Diseases, Immunology, Cardiology, Other Applications. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Precision Medicine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Precision Medicine Market Segmentation Technology

  1. Drug Discovery
  2. Companion Diagnostics
  3. Gene Sequencing
  4. Bio-Informatics
  5. Big Data Analytics

Application

  1. Oncology
  2. Respiratory
  3. CNS
  4. Infectious Diseases
  5. Immunology
  6. Cardiology
  7. Other Applications
Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Precision Medicine Market: Strategic Insights

precision-medicine-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Precision Medicine Market Growth Drivers

  1. Genomic and Molecular Biology: Genomic and molecular biology are the engines for precision medicine. The sequencing and interpretation of genetic material led to personalised treatments in which therapies are individualised by genetic code, lifestyle and environment. A rising consciousness of the human genome is opening up new therapeutic applications for precision medicine in oncology, rare diseases and chronic disease.
  2. The Growth of Chronic Diseases and Cancer: Growing chronic diseases such as cancer, cardiovascular disease, diabetes and so on are driving the precision medicine. The more patients who want to be treated based on their own genetic characteristics, the more needed personalized treatments and genetic tests that could lead to better patient outcomes.
  3. Broad Regulatory Approval: Governments like FDA and EMA have gotten more open to precision medicine, allowing targeted treatments and companion diagnostics to allow for tailor-made treatment plans. Not only do these regulatory approvals fuel precision medicineReport Scope

    Precision Medicine Market Regional Insights

    The regional trends and factors influencing the Precision Medicine Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Precision Medicine Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

    Precision Medicine Market Report Scope

    By Application
    • Oncology
    • Respiratory
    • CNS
    • Infectious Diseases
    • Immunology
    • Cardiology
    • Other Applications
    Europe
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
    Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
    South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America
    Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
    Report Attribute Details
    Market size in 2024 US$ XX Billion
    Market Size by 2031 US$ 271.17 billion
    Global CAGR (2025 - 2031) 12.8%
    Historical Data 2021-2023
    Forecast period 2025-2031
    Segments Covered By Technology
    • Drug Discovery
    • Companion Diagnostics
    • Gene Sequencing
    • Bio-Informatics
    • Big Data Analytics
    Regions and Countries Covered North America
    • US
    • Canada
    • Mexico
    Market leaders and key company profiles
    • F. Hoffmann-La Roche Ltd
    • Quest Diagnostics Incorporated
    • Novartis AG
    • Bristol-Myers Squibb Company
    • Medtronic
    • QIAGEN
    • Pfizer Inc.
    • Thermo Fisher Scientific Inc.
    • Eli Lilly and Company

    Precision Medicine Market Players Density: Understanding Its Impact on Business Dynamics

    The Precision Medicine Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    precision-medicine-market-cagr
    • Get the Precision Medicine Market top key players overview

Frequently Asked Questions

1

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
2

What are the deliverable formats of the Precision Medicine Market?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
3

Which are leading players in Precision Medicine Market?

The leading players are F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Novartis AG, Bristol-Myers Squibb Company, Medtronic, QIAGEN, Pfizer Inc., Thermo Fisher Scientific Inc., Eli Lilly and Company, AstraZeneca,
4

What is the expected CAGR in Precision Medicine Market?

The market is expected to register a CAGR of 12.8% during 2025-2031.
5

What are driving factors impacting the Precision Medicine Market?

Rapidly rising healthcare expenditure, advancement in genetic testing, migration towards personalized treatments, and integration of big data and AI in healthcare are the prime growth factors for Precision Medicine Market.
6

What are the future trends of Precision Medicine Market?

Future trends include increased use of genomic data in developing tailored treatments, expansion of personalized cancer therapies, and increased integration of AI and machine learning in drug development.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo